# Michele Buemi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michele-buemi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11,246 |
| Field | Erythropoietin and Anemia Treatment |
| h-index | 55 |
| i10-index | 200 |
| Last Known Institution | University of Messina |
| OpenAlex ID | https://openalex.org/A5108079589 |
| Works | 443 |

## Researcher papers

- [Adiponectin, Metabolic Risk Factors, and Cardiovascular Events among Patients with End-Stage Renal Disease](https://scholariq.org/papers/adiponectin-metabolic-risk-factors-and-cardiovascular-events-among-patients-with/)
- [Neutrophil Gelatinase–Associated Lipocalin (NGAL) as a Marker of Kidney Damage](https://scholariq.org/papers/neutrophil-gelatinase-associated-lipocalin-ngal-as-a-marker-of-kidney-damage/)
- [Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease](https://scholariq.org/papers/neutrophil-gelatinase-associated-lipocalin-ngal-and-progression-of-chronic/)
- [Vascular access for hemodialysis: current perspectives](https://scholariq.org/papers/vascular-access-for-hemodialysis-current-perspectives/)
- [Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation](https://scholariq.org/papers/erythropoietin-protects-against-brain-ischemic-injury-by-inhibition-of-nitric/)
- [Neutrophil Gelatinase-Associated Lipocalin as an Early Biomarker of Nephropathy in Diabetic Patients](https://scholariq.org/papers/neutrophil-gelatinase-associated-lipocalin-as-an-early-biomarker-of-nephropathy/)
- [Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage](https://scholariq.org/papers/beneficial-effects-of-systemic-administration-of-recombinant-human/)
- [Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis](https://scholariq.org/papers/leptin-increases-serotonin-turnover-by-inhibition-of-brain-nitric-oxide/)
- [Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: A new protein enters the scene](https://scholariq.org/papers/neutrophil-gelatinase-associated-lipocalin-ngal-in-human-neoplasias-a-new/)
- [Neutrophil Gelatinase-Associated Lipocalin in Patients with Autosomal-Dominant Polycystic Kidney Disease](https://scholariq.org/papers/neutrophil-gelatinase-associated-lipocalin-in-patients-with-autosomal-dominant/)
- [Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis](https://scholariq.org/papers/emerging-therapeutic-strategies-for-minimal-change-disease-and-focal-and/)

## Researcher topics

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)

## Researcher university

- [University of Messina](https://scholariq.org/institutions/university-of-messina/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.